Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases – PR Newswire

Leave a Comment / Pharma and Biotech / By

Talawar Therapeutics and JATT II buyout Corp. Announce Definitive Business Combination pact to Create Publicly Listed Biotechnology firm Developing Potentially Best-in-Class Bispecifics for I&I Diseases PR Newswire

Source: news.google.com

Leave a Comment Cancel Reply